Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gemina Laboratories Ltd
(CSE:
GLAB
)
0.4500
UNCHANGED
Last Price
Updated: 10:39 AM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
0.4500
Bid (Size)
0.4400 (11,500)
Ask (Size)
0.4600 (500)
Prev. Close
0.4500
Today's Range
0.4500 - 0.4500
52wk Range
0.2000 - 0.6000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Gemina Laboratories Strategic Update
July 10, 2024
Via
ACCESSWIRE
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
June 21, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Performance
YTD
-18.18%
-18.18%
1 Month
N/A
N/A
3 Month
+1.12%
+1.12%
6 Month
-2.17%
-2.17%
1 Year
-10.00%
-10.00%
More News
Read More
Gemina Laboratories Commences Trading on the OTCQB Market in the United States
June 20, 2024
Via
ACCESSWIRE
Life Sciences Virtual Investor Forum Agenda Announced for June 20th
June 18, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Labs Announces Addition to its IP Portfolio
April 09, 2024
Via
ACCESSWIRE
Gemina Laboratories to Participate in Poster Session at American Association of Clinical Chemistry Annual Scientific Meeting
June 15, 2023
Via
ACCESSWIRE
Gemina Labs to Present at the Life Science Investor Forum June 20th
June 17, 2024
From
Virtual Investor Conferences
Via
GlobeNewswire
Gemina Laboratories Sign First Strategic License Agreement
April 02, 2024
Via
ACCESSWIRE
Gemina Labs Strategic Update: Focusing on Respiratory Infections and Strategic Partnerships
March 21, 2024
Via
ACCESSWIRE
Gemina Announces Closing of $910,000 Convertible Note Financing
March 19, 2024
Via
ACCESSWIRE
Gemina's Recent Investment into RAPIvD Sees Immediate Progress
December 13, 2022
Via
ACCESSWIRE
ReadyGo Diagnostics Initiates An Assay Development Contract With Gemina Laboratories For The Detection Of Dengue From Saliva Samples
October 10, 2023
Via
Get News
Gemina Laboratories Announces Major Breakthrough in Environmentally Friendly Lateral Flow Test Design by Removing the Requirement for Nitrocellulose
July 25, 2023
Via
ACCESSWIRE
Gemina Laboratories and ReadyGo Diagnostics Achieve Mycobacterium Tuberculosis Diagnosis in Saliva
June 05, 2023
Via
ACCESSWIRE
Gemina Labs Antibody Immobilization Chemistry Platform Demonstrates Major Lateral Flow Assay Performance Improvement
May 17, 2023
Via
ACCESSWIRE
Gemina Laboratories to Host Investor Webinar on March 30, 2023
March 27, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Diagnostic Strategist Martha Najib to the Board
March 07, 2023
Via
ACCESSWIRE
Gemina Labs Announces Appointment of Healthcare Industry Leader Dr. Bola Grace to The Board of Directors
January 25, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Top Ranked UK Analyst and Scientist, Dr. Stefan Hamill as Vice President, Strategy
January 23, 2023
Via
ACCESSWIRE
Gemina Labs Strategic Update: Respiratory Infections the Immediate Focus and New Strategic Partnerships on the Horizon
January 10, 2023
Via
ACCESSWIRE
Gemina Labs Completes Influenza A/B Diagnostic Test Prototype
January 06, 2023
Via
ACCESSWIRE
Gemina Labs Appoints Dr Michael Shannon as Chair of Clinical Advisory Board
December 20, 2022
Via
ACCESSWIRE
Gemina Labs Announces Research Collaboration on Next Generation Biosensors
December 19, 2022
Via
ACCESSWIRE
Gemina Labs Announces Strategic Stake in British Rapid Test Optimizer Rapivd Limited
December 07, 2022
Via
ACCESSWIRE
Gemina Labs Enters into Licence and Manufacturing Agreements
October 06, 2022
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.